Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution series

Fig. 1

Kaplan-Meier analysis of the 3-year overall survival (OS) and recurrence-free survival (RFS) rates of patients with gastric neuroendocrine neoplasms (g-NENs) stratified according to the presence of sarcopenia (a-b) and pathological types: c-d gastric neuroendocrine tumor (gNET), e-f gastric neuroendocrine carcinoma (gNEC), and (g-h) gastric mixed adenoneuroendocrine carcinoma (gMANEC)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us